Dabigatran etexilate retards the initiation and progression of atherosclerotic lesions and inhibits the expression of oncostatin M in apolipoprotein E-deficient mice
Michael R Preusch,1,2 Nicholas Ieronimakis,1 Errol S Wijelath,3 Sara Cabbage,1 Jerry Ricks,1 Florian Bea,2 Morayma Reyes,1 Joanne van Ryn,4 Michael E Rosenfeld1,5 1Department of Pathology, University of Washington, Seattle, WA, USA; 2Department of Internal Medicine, University of Heidelberg, Heidelb...
Saved in:
Main Authors: | Preusch MR (Author), Ieronimakis N (Author), Wijelath ES (Author), Cabbage S (Author), Ricks J (Author), Bea F (Author), Reyes M (Author), van Ryn J (Author), Rosenfeld ME (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Discovery of Dabigatran Etexilate
by: Joanne evan Ryn, et al.
Published: (2013) -
DABIGATRAN ETEXILATE FOR THE TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS
by: N. M. Vorobieva, et al.
Published: (2015) -
The Complementary Effects of Dabigatran Etexilate and Exercise Training on the Development and Stability of the Atherosclerotic Lesions in Diabetic ApoE Knockout Mice
by: Nikolaos PE Kadoglou, et al.
Published: (2023) -
Dabigatran etexilate - A novel oral anticoagulant for bleeding complications
by: Himabindu Reddy, et al.
Published: (2015) -
Monitoring the use of dabigatran etexilate for stroke prevention: compliance with renal function guidelines
by: Alesha J. Smith, et al.
Published: (2020)